Focuses on the possible relaxation of ban on federal funding for researches involving human embryos in the United States. Achievements in the field of human embryonic stem cell by biotechnology companies Geron Corp. and Advanced Cell Technology Inc.; Potential medical benefits from researches involving human embryos; Scientific and ethical effects of easing of the federal ban.